Paperonium

Diabetes drugs · Cell Rep · 2026

The summary says metformin raises a sugar-releasing gut enzyme; the paper’s own measurements show it falls.

The summarymore G6PC in gut cellssame as untreatedMice given metforminless G6PC in gut cellsGut cells in a dishless G6PC; its gene less activeIts main textten statements say it falls
The summarymore G6PC in gut cellssame as untreatedMice given metforminless G6PC in gut cellsGut cells in a dishless G6PC; its gene less activeIts main textten statements say it falls

Which way metformin moves G6PC, the enzyme that lets sugar out of gut cells

The paper says

G6PC is an enzyme (a protein that does one chemical job) in gut cells: it strips a chemical tag off sugar so the sugar can leave the cell. The summary says high levels of the diabetes drug metformin raise G6PC “to prevent glucose release”.

Its own data show

Every measurement of metformin’s effect on gut-cell G6PC shows a fall, in mice and in cells in a dish. Treated cells had 5 times the tagged sugar of untreated ones, and less free sugar: what falling G6PC would cause. Ten statements say it falls; three say it rises: two summaries and a heading.

G6PC lets sugar out, so raising it would release more sugar, not “prevent glucose release”. Less G6PC keeps sugar in the gut cell to be broken down there: step one of the paper’s account of metformin in the gut. The data stand, but the summary, the most-read part, has that step backwards: “upregulate” should be “downregulate”.

“The summary” means the paper’s abstract: the short summary printed at its top, which is the part most readers see.

Read the paper →Full technical write-up →

The coordinated actions of metformin in the intestine and liver improves hyperglycemia · Cell Rep (2026) · doi:10.1016/j.celrep.2026.117791